Abstract
This study aimed to systematically evaluate the effectiveness and safety of telemedicine in improving the corresponding indicators in patients with rheumatoid arthritis (RA).Computer searches of PubMed, Embase, the Cochrane Library, and Web of Science were conducted to collect journal articles on randomized controlled trials and clinical trials of telemedicine interventions for RA. A meta-analysis was performed using the risk-of-bias assessment tool Reedman 5.4 software from the Cochrane Handbook.The systematic assessment includes 17 studies totaling 2,324 patients, with a middling level of quality across the included research. The findings of this study demonstrated that individuals with RA had better treatment efficiency in C-reactive protein than those in the control group (mean difference [MD] = - 21.17, 95% confidence interval [CI] = - 49.57 to 7.23; p < 0.00001), Rheumatoid Arthritis Quality of Life (MD = - 1.97, 95% CI = - 6.13 to 2.19; p = 0.01), and visual analog scale pain (MD = - 8.53, 95% CI = - 22.70 to 5.64; p = 0.04).Patients with RA can access specialists worldwide through telemedicine, which can raise the overall quality of care for RA patients. It has shown to be quite successful in identifying and evaluating disease activity. By making patient-centeredness a central factor in the decision-making process, telemedicine improves equitable results and offers customized treatment regimens.